Cwm, LLC Hille Vax, Inc. Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Cwm, LLC holds 14 shares of HLVX stock, worth $24. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 3 366.67%

Holding current value

$24

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 09, 2024	BUY	$11.86 - $15.93 $130 - $175	11 Added 366.67%	14 $0
Q1 2024 Apr 05, 2024	BUY	$14.15 - $19.75 $42 - $59	3 New	3 $0

Others Institutions Holding HLVX

# of Institutions

Shares Held

40.5M

Call Options Held

Put Options Held

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.6M
Shares

$18.7 Million
9.05% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

4M
Shares

$7.05 Million
1.22% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.48M
Shares

$6.13 Million
0.03% of portfolio
Black Rock Inc. New York, NY

2.09M
Shares

$3.68 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

1.99M
Shares

$3.5 Million
0.01% of portfolio

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $58.8M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account